Existing data sources for clinical epidemiology: The Danish National database of reimbursed prescriptions

Clinical Epidemiology

Volumn 4, Issue 1, 2012, Pages 303-313

  Johannesdottir, Sigrun Alba ^a   Horváth Puhó, Erzsébet ^a   Ehrenstein, Vera ^a   Schmidt, Morten ^a   Pedersen, Lars ^a   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Denmark; Patient registration; Pharmacoepidemiology; Registry based research

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; ANTIRETROVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; IMMUNOMODULATING AGENT; METHADONE; NON PRESCRIPTION DRUG; ORAL CONTRACEPTIVE AGENT; VACCINE;

ACCESS TO INFORMATION; ARTICLE; BIOSTATISTICS; CARDIOVASCULAR SYSTEM; DANISH NATIONAL DATABASE OF REIMBURSED PRESCRIPTIONS; DATA ANALYSIS; DATA BASE; DENMARK; DIGESTIVE SYSTEM; DRUG RESEARCH; ELECTRONIC MEDICAL RECORD; EPIDEMIOLOGICAL DATA; GENERAL PRACTITIONER; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL CARE; MEDICAL RESEARCH; OUTPATIENT DEPARTMENT; PHARMACY; PRESCRIPTION; QUALITY CONTROL; REGISTRATION; REIMBURSEMENT; RESPIRATORY SYSTEM;

EID: 84869182583     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/clep.s37587     Document Type: Article

References (32)

1. National Health Inusrance Research Database [database on the Internet]. Taiwan. Available from: http://nhird.nhri.org.tw/en/index.htm. Accessed July 18, 2012.
2. Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106(2):86-94.
3. García Rodríguez LA, Pérez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol. 1998;45(5):419-425.
4. Kozyrskyj AL, Mustard CA. Validation of an electronic, population-based prescription database. Ann Pharmacother. 1998;32(11): 1152-1157.
5. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol. 1989;129(4):837-849.
6. van Herk-Sukel MP, van de Poll-Franse LV, Lemmens VE, et al. New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System. Eur J Cancer. 2010;46(2):395-404.
7. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323-337.
8. Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(Suppl 7):22-25.
9. Danish Health and Medicines Authority [webpage on the Internet]. Statistics and analyses. Denmark: Danish Health and Medicines Authority; 2012 [updated June 15, 2012]. Available from: http://laegemiddelstyrelsen.dk/en/topics/statistics,-prices-and-reimbursement/statistics-and-analyses. Accessed June 13, 2012.
10. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(Suppl 7):38-41.
11. The Danish Data Protection Agency [webpage on the Internet]. The Act on Processing of Personal Data [in Danish: Persondataloven]. Denmark: The Danish Data Protection Agency; 2007 [updated September 29, 2011]. Available from: http://www.datatilsynet.dk/lovgivning/persondataloven/. Accessed June 13, 2012.
12. Ministry of Health and Prevention. Health Care in Denmark. Denmark: Ministry of Health and Prevention; 2008. Available from: http://www.sum.dk/Aktuelt/Publikationer/~/media/Filer-Publikationer_i_pdf/2008/UK_Healthcare_in_dk/pdf.ashx. Accessed June 13, 2012.
13. Danish Health and Medicines Authority [webpage on the Internet]. Drug statistics in Denmark 2006-2010. Denmark: Danish Health and Medicines Authority; 2012 [created August 5, 2011]. Available from: http://laegemiddelstyrelsen.dk/en/topics/statistics,-prices-and-reimbursement/statistics-and-analyses/statistics/report-on-the-annual-sale-of-medicines---medstatdk/drug-statistics-2006-2010. Accessed June 13, 2011.
14. Danish Health and Medicines Authority [webpage on the Internet]. Reimbursement. Denmark: Danish Health and Medicines Authority; 2012 [updated April 24, 2012]. Available from: http://laegemiddelstyrelsen.dk/en/topics/statistics,-prices-and-reimbursement/reimbursement. Accessed June 13, 2012.
15. Ehrenstein V, Antonsen S, Pedersen L. Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol. 2010;2:273-279.
16. Official homepage of the Danish Health and Medicines Authority [homepage on the Internet]. Denmark: Danish Health and Medicines Authority; 2012. Available from: http://laegemiddelstyrelsen.dk/en/. Accessed June 13, 2012.
17. WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health [webpage on the Internet]. ATC/DDD-History. Norway: WHO Collaborating Centre for Drug Statistics Methodology; 2009 [updated November 19, 2009]. Available from: http://www.whocc.no/atc_ddd_methodology/history/. Accessed June 13, 2012.
18. Grove Krause T, Jakobsen S, Haarh M, Mølbak K. The Danish vaccination register. Euro Surveill. 2012;17(17).
19. Nielsen GL, Sørensen HT, Pedersen AB, Sabroe S. Analyses of data quality in registries concerning diabetes mellitus-a comparison between a population based hospital discharge and an insulin prescription registry. J Med Syst. 1996;20(1):1-10.
20. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(Suppl 7):30-33.
21. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(Suppl 7):42-45.
22. The Danish State Serum Institute [homepage on the Internet]. Statistics on aggregate sales data. Denmark: The Danish State Serum Institute; 2012. Available from http://www.medstat.dk. Accessed June 13, 2012.
23. Johannesdottir SA, Mægbæk ML, Hansen JG, Lash TL, Pedersen L, Ehrenstein V. Correspondence between general practitioner-reported medication use and timing of prescription dispensation. Clin Epidemiol. 2012;4:13-18.
24. Sørensen HT, Sabroe S, Olsen J. A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol. 1996;25(22):435-442.
25. Johnsen SP, Larsson H, Tarone RE, et al. Risk of Hospitalization for Myocardial Infarction Among Users of Rofecoxib, Celecoxib, and Other NSAIDs: A Population-Based Case-Control Study. Arch Intern Med. 2005;165(9):978-984.
26. Johnsen SP, Pedersen L, Friis S, et al. Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control study. Stroke. 2003;34(2): 387-391.
27. Schmidt M, Christiansen CF, Horváth-Puhó E, Glynn RJ, Rothman KJ, Sørensen HT. Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism. J Thromb Haemost. 2011; 9(7):1326-1333.
28. Schmidt M, Christiansen CF, Mehnert F, Rothman KJ, Sørensen HT. Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study. BMJ. 2011;343:d3450.
29. Johannesdottir SA, Chang ET, Mehnert F, Schmidt M, Olesen AB, Sørensen HT. Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: A population-based case-control study. Cancer. 2012;118(19):4768-4776.
30. Nielsen GL, Sørensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ. 2001;322(7281):266-270.
31. Riahi S, Fonager K, Toft E, et al. Use of lipid-lowering drugs during 1991-1998in Northern Jutland, Denmark. Br J Clin Pharmacol. 2001;52(3):307-311.
32. Thrane N, Sørensen HT. A one-year population-based study of drug prescriptions for Danish children. Acta Paediatr. 1999;88(10):1131-1136.